Next Article in Journal
Effect of Climate Change on CO2 Flux in Temperate Grassland, Subtropical Artificial Coniferous Forest and Tropical Rain Forest Ecosystems
Previous Article in Journal
eHealth and mHealth Development in Spain: Promise or Reality?
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Nicotine Dependence in Patients with Major Depressive Disorder and Psychotic Disorders and Its Relationship with Quality of Life

1
Research Division, Institute of Mental Health, Buangkok Green Medical Park, 10 Bunagkok View, Singapore 539747, Singapore
2
Early Psychosis Intervention Programme, Institute of Mental Health, Singapore 539747, Singapore
3
Office of Education, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore
4
Department of Mood and Anxiety, Institute of Mental Health, Buangkok Green Medical Park, 10 Buangkok View, Singapore 539747, Singapore
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2021, 18(24), 13035; https://doi.org/10.3390/ijerph182413035
Submission received: 17 November 2021 / Accepted: 7 December 2021 / Published: 10 December 2021
(This article belongs to the Section Mental Health)

Abstract

:
The aim of the current study was to examine the associations between nicotine dependence and quality of life (QOL) among individuals diagnosed with major depressive disorder (MDD) or psychotic disorders. Methods: A total of 378 participants diagnosed with either MDD or psychotic disorders were recruited. The Fagerstorm Test for Nicotine Dependence was used to measure the level of nicotine dependence. The SF-12 health survey questionnaire was used to measure the QOL. Results: The prevalence of nicotine dependence was 23.3% in this sample population. For those diagnosed with MDD, moderate level of nicotine dependence was negatively associated with Vitality and Mental Component Score. For those diagnosed with a psychotic disorder high nicotine dependence was negatively associated with Role Emotional, Mental Health and Mental Component Score. Discussion: Compared to the general population, the prevalence of smoking in this psychiatric population was 2.4 times higher, while that of nicotine dependence was seven times higher. Individuals with psychotic disorder generally reported better QOL as compared to individuals with MDD. QOL differed across diagnostic groups with regards to socio-demographics, such as age, ethnicity, marital status, education, employment status and monthly income. Among individuals with MDD and psychotic disorders, different levels of nicotine dependence resulted in different levels of association with QOL. More research is needed to better understand the differences in QOL among the varying levels of nicotine dependence.

1. Introduction

Smoking is a leading cause of preventable death worldwide [1]. The World Health Organisation (WHO) has estimated that every year more than eight million people die due to smoking-related diseases [1]. Smoking-related diseases contribute significantly to the global rise in non-communicable diseases in both developed and developing countries. Smoking has been linked to cancer, cardiovascular diseases, stroke, and other diseases [2]. Moreover, the mortality rate of smokers is three times higher, and they die an average of 10 years earlier than non-smokers [3]. Cigarettes are the most commonly used form of tobacco product worldwide [1]. Other forms of tobacco use include cigars, roll your own tobacco, pipes, shisha, and the most recently introduced electronic nicotine delivery systems (ENDS) [1]. Nicotine is the key chemical compound that causes tobacco use disorder. In recent years, the design and contents of emerging tobacco products have made smoking novel, highly addictive, and more damaging to health as compared to the past [1]. For example, the introduction of ENDS is appealing because of its slim design, different colours and flavours [4]. Furthermore, the formulation of e-cigarettes increases the rate of nicotine delivery and decreases the harsh sensation in the throat, making it appealing and addictive [4].
A steady decline in smoking prevalence rates in western countries has been reported [5]. Similarly, in Singapore, the prevalence of daily smoking had dropped from 14.3% in 2010 to 12% in 2017 [6,7]. An epidemiological study conducted in 2012 among individuals aged 18 years and above showed that 16.3% of the resident population were current smokers [8]. More recently, a national survey using the same methodology showed no change in the prevalence of smoking in Singapore (16.1%) [9]. The authors reported that the prevalence of nicotine dependence was on a downward trend from 4.5% in 2012 to 3.3% in 2016 [9].
Notwithstanding the above, there are certain subgroups who are more prone to smoking and nicotine dependence. Individuals with mental disorders smoke at rates approximately double that compared to individuals who do not have mental disorders [10], especially those diagnosed with major depressive disorder (MDD) and schizophrenia [11]. The predisposition towards smoking could be due to poor coping strategies, smoking as a self-medication to cope with symptoms of mental illness, or as social reinforcement where smoking is a social activity or culture in mental health facilities and to avoid the higher severity of withdrawal symptoms [12,13]. They also tend to smoke more heavily, which means that this group faces greater risks of health problems related to smoking [10]. In addition to this, individuals with mental disorders experience up to 25 years of reduced life expectancy compared to the general population [14]. Much of this reduction in life expectancy can be attributed to smoking-related diseases, making it important to track and monitor smoking and nicotine dependence rates among the mentally ill [11].
Both schizophrenia and depression can affect an individual’s quality of life. Socio-demographic correlates such as female gender, younger age, marital status, and lower education are associated with better quality of life (QOL) in schizophrenia patients [15]. Positive symptoms such as hallucinations and delusions in schizophrenia can significantly impair functioning [16]. Negative symptoms are similarly associated with poorer mental and physical functioning [16]. Studies have indicated that MDD accounts for severely impaired work ability, social ability, and emotional and physical functioning. Those with MDD are less likely to graduate from school, more likely to report poor quality of interpersonal relationships, and more likely to divorce than individuals without MDD [17].
WHO defined quality of life as an individual’s perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards, and concerns [18]. Many QOL measurement tools have been developed and validated over the years. These tools assess QOL as a multidimensional construct, including physical, psychological, and social functioning [19]. With the emphasis on holistic care, QOL has gained traction in mental health services to address the psychosocial aspect of mental health. A systematic review conducted in 2019 concluded that QOL is an important endpoint in medical and health research [20].
Studies have investigated the relationship between smoking cessation and QOL. In 2014, a systematic review concluded that smoking cessation improves QOL and mood while reducing symptoms of anxiety and depression [21]. Although effective, smoking cessation is often overshadowed by managing an individual’s mental disorder coupled with the difficulty of getting smokers to quit and to stay quit [22]. Despite the well-established risk of diseases associated with smoking, to the best of our knowledge, there is a dearth of studies investigating associations between nicotine dependence and QOL among individuals with mental illness. Studies have also not compared nicotine dependence across mental disorders and whether it impacts QOL differently across disorders. The association between QOL and smoking may have an influence on the ability of the smoker to reduce or stop smoking. Goldenberg and colleagues [23] suggested, that understanding the relationship between QOL and smoking initiation can inform prevention efforts. By understanding the impact of nicotine dependence on QOL, the information can be used to improve the motivation to quit, and enhance relapse prevention strategies.
Therefore, the present study aims to examine the associations between nicotine dependence and QOL among individuals diagnosed with MDD or psychotic disorders. We will also examine how varying levels of nicotine dependence affect QOL. Such findings are necessary to better inform interventions aimed at smoking cessation and improving the physical and psychological health of people with serious mental illness.

2. Methodology

Participants

Data were collected from October 2018 to February 2020. Participants were recruited from the inpatient wards or outpatient clinics at the Institute of Mental Health, the only tertiary psychiatric care hospital in Singapore. Participants were recruited through (a) referrals by the attending clinician and (b) self-referrals in response to the recruitment posters displayed at the clinics. Trained study team members screened the participants to ensure that the inclusion criteria were met. Participants had to meet the following eligibility criteria: (1) Singapore citizen or permanent resident (2) aged 21 to 65 years old (3) diagnosis of either MDD or schizophrenia spectrum and other psychotic disorders. The study team members confirmed the eligibility of the participants against the medical records before administering the questionnaires. The study excluded participants who did not have the mental capacity to consent to the study or did not meet the diagnostic criteria. The diagnosis of mental disorders was based on the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) criteria [24]. The survey was administered in either one of the four local languages: English, Chinese, Malay, or Tamil, as preferred by the participants. Ethics approval was obtained from the Institutional Research Review Committee, and Domain Specific Review Board of the National Healthcare Group (Ref: 2018/00772), and written consent was granted by all participants.

3. Materials Used

3.1. Socio-Demographic Questionnaire

A modified version of the Global Adult Tobacco Survey [25] was used to capture data that included sociodemographic information (e.g., age, sex, ethnicity, education, housing, and income) and questions regarding smoking status. The classification of a smoker, non-smoker, and past smoker was based on the definitions from the National Health Interview Survey [26]. Participants who self-reported a lifetime smoking of at least 100 cigarettes and were smoking at the time of the survey were classified as smokers, and those who had smoked 100 cigarettes in their lifetime and had quit smoking were classified as former smokers [26]. Non-smokers were those who had never smoked 100 cigarettes in their lifetime. For the purpose of data analysis and interpretation, ex-smokers were subsumed under the category for current smokers to form a new category of “ever-smokers” because of the small sample size and the need to keep to the convention set by the first article published for this project [27]. The diagnosis was based on the clinician report, which was extracted from the medical records.

3.2. Fagerstrom Test of Nicotine Dependence (FTND)

The level of nicotine dependence was measured using the Fagerstrom Test for Nicotine Dependence (FTND) [28]. This scale consists of six items regarding daily cigarette consumption and assesses the extent of cigarette smoking and smoking behaviour. The number of response options varies for each item, and response options are given a score of 0, 1, 2, or 3. Items are then summed to give a total score ranging from 0 to 10. Scores of 0 to 4 are classified as low dependence, 5 to 7 as moderate and 8 and above are classified as high dependence [27]. We categorized those with scores of 5 and above as having nicotine dependence, as defined by a previous study [9]. The FTND has been shown to have adequate validity [28] and is also a reliable tool for the assessment of smoking behaviour in patients with schizophrenia [29].

3.3. 12-Item Short Form Survey (SF-12)

The SF-12 questionnaire developed for the Medical Outcomes Study was used to assess QOL [30]. This scale includes 12 items covering eight domains of health status: Physical Functioning (PF), Role-Physical (RP), Bodily Pain (BP), General Health (GH), Vitality (VT), Social Functioning (SF), Role-Emotional (RE) and Mental Health (MH). The Physical Component Score (PCS) summarizes PF, RP, BP, and GH while the Mental Component Score (MCS) reflects VT, SF, RE, and MH. These scores range from 0 to 100 and are calculated by the standard algorithm described in the SF-12 manual [25]. A score of 0 indicates the lowest level of health measured and a score of 100 indicates the highest level of health. The SF-12 has been tested and validated in Asian populations, including Hong Kong [31], and Singapore [32].

4. Statistical Analysis

Descriptive statistics were tabulated for the overall sample. Means and standard deviations were calculated for continuous variables and frequencies and percentages for categorical variables. Multiple linear regression was used to examine the associations between QOL, socio-demographic variables, and mental disorders in the overall sample. Diagnosis-specific analyses were also conducted to explore the socio-demographic correlates of QOL as well as the association between nicotine dependence and QOL. The following variables were controlled for: age, gender, ethnicity, education, marital status, employment status, monthly income, and type of diagnosis. Respondents who had any missing values on any variables were removed from the analysis: one current smoker and one ex-smoker had missing values on the FTND questionnaire. All statistical analyses were carried out using Statistical Analysis Software (SAS) System version 9.2. Statistical significance was evaluated at the ≤0.05 level using two-sided tests.

5. Results

5.1. Descriptive Statistics

A total of 380 participants were recruited, and two cases were removed listwise from the analysis due to missing data. Table 1 shows the sociodemographic characteristics and smoking habits of the participants. Among the 378 participants recruited, about half the participants (46.3%) were diagnosed with MDD, while the remaining 53.7% were diagnosed with psychotic disorders. About 66.3% of participants with MDD were between 21 and 40 years old, while 35% of the participants with a psychotic disorder were 21 to 40 years old. The prevalence of smoking was 39.5%, as reported in an earlier paper [27]. Among the sample of MDD individuals, 46.9% were non-smokers, 36.6% had low dependence, 14.3% had moderate, and 2.3% had a high nicotine dependence. Among the sample of psychotic disorders, 56.2% were non-smokers, 14.8% had low dependence, 19.2% had moderate, and 9.9% had a high nicotine dependence.

5.2. Association of Sociodemographic Factors with QOL

Table 2 shows the association of sociodemographic factors with QOL for the MDD sample. Participants aged 41 to 65 years old were negatively associated with PCS (β = −5.01, p = 0.007) and positively associated with MCS (β = 6.33, p = 0.009). Compared to Chinese ethnicity, Indians were negatively associated with BP (β =−6.48, p = 0.02), PCS (β = −5.03, p = 0.009). Being single was negatively associated with BP (β = −6.24, p = 0.024), VT (β = −4.55, p=0.033) and PCS (β = −4.25, p = 0.025). Those with secondary educations were negatively associated with BP (β = −7.04, p = 0.045) and MH (β =−6.55, p = 0.025), as compared to those who were university educated. Those with pre-university were negatively associated with VT (β = −5.26, p = 0.011) and MCS (β = −5.70, p = 0.018). Compared to those with a monthly income of below $2000, those with a monthly income of $2000 to $3999 were negatively associated with VT(β = −4.42, p = 0.039).
Among those with a psychotic disorder (Table 3), 41 to 65 years was negatively associated with PCS (β = −3.59, p = 0.013). Compared to Chinese ethnicity, Malays were positively associated with VT (β = 6.10, p = 0.016), SF (β = 4.90, p = 0.048) and MCS (β = 5.21, p = 0.024). Indians were also positively associated with SF (β = 8.89, p = 0.007) and MCS (β = 7.29, p = 0.017). Compared to those with a university education, those who were vocationally trained were negatively associated with RP (β = −5.81, p = 0.045) and VT (β = −8.41, p = 0.016). Those who are economically inactive were negatively associated with SF (β = −6.97, p = 0.032) as compared to those who were employed.

5.3. Association between Nicotine Dependence and QOL in MDD and Psychotic Disorder

As reflected in Table 4, moderate nicotine dependence was negatively associated with VT (β = −5.11, p = 0.041) and MCS (β = −5.77, p = 0.046) in the MDD subgroup. High nicotine dependence was not significantly associated with any QOL subdomains in the MDD. Among the psychotic disorder subgroup, high nicotine dependence was negatively associated with RE (β = −7.81, p = 0.018), MH (β = −6.59, p = 0.021) and MCS (β = −7.09, p = 0.012).

6. Discussion

Our findings showed that the prevalence of current smoking (39.4%) in the psychiatric population was 2.4 times higher than that of the general population (16.1%) [9]. This is in line with previous studies where a higher prevalence of smoking was reported among people with mental illness [10,33]. We also found that 23.3% of the psychiatric population was nicotine dependent. This figure is seven times higher than that of the general population, which is reported to be at 3.3% [9]. Similarly, this is consistent with an overseas study whereby those with psychiatric disorders were two to 16 times more likely to have nicotine dependence than those without these diagnoses [34]. Researchers had also reported that those with a diagnosed mental illness were 25% less likely to quit smoking [10,33] and had a lower readiness to quit [27]. The high prevalence of nicotine dependence and lower probability of smoking cessation in this group is a concern for public health professionals and physicians to note, as they would require more intensive intervention to reduce or stop their smoking behavior.
Both psychosis and MDD can affect an individual’s overall quality of life. In this study, QOL differed across the two diagnostic groups based on sociodemographics factors such as age, ethnicity, marital status, education, employment status, and monthly income. Older individuals with MDD reported better mental health scores (MCS) and poorer physical health scores (PCS) than their younger counterparts. The association of older age with poorer PCS was not unusual, as older participants would more likely experience limitations to their physical health as compared to those in the younger age group, leading to lower PCS. Previous studies have suggested that a curvilinear relationship between age and QOL exists, whereby life satisfaction peaked at 65 years, and happiness peaked at 50 years [35,36]. This may explain why compared to the younger counterparts, the older individuals had a higher scores in their MCS. Compared to those of Chinese ethnicity, Indians were negatively associated with BP, which may have negatively affected the PCS. The differences of pain perception within the ethnic groups are similar to what has been previously reported in the general population [37]. In a national survey of Singaporean adults, Indian participants reported greater pain severity when compared with both Malay and Chinese participants [37].
Similarly, being single and having a secondary school education was negatively associated with BP. These relationships were not observed among individuals with psychosis. Being married enables individuals to share resources such as finances, food, social support, workload and responsibilities. These resources may act as a buffer against BP and VT, which are not readily available to single people. Individuals who have attained an education lower than university were negatively associated with various subdomains of QOL. Generally, individuals with higher education can hold a better-paying job which could, in turn, lead to better health and well-being [38]. They might also be more knowledgeable about the determinants of their health and are hence able to adopt a better lifestyle, leading to better functional outcomes.
As compared to those with MDD, individuals diagnosed with psychotic disorder reported better QOL in almost all subdomains (refer to Table 3). This result is in line with previous studies whereby individuals with schizophrenia reported better QOL as compared to those with MDD [39,40]. The authors suggest that there are underlying differences, as individuals with psychosis may lack insight into their illness and social environment. Thus, they may develop protective strategies (i.e., denial, minimization) and assign meaning to their lives, leading to better QOL than individuals with depression [40]. On the other hand, individuals with depression experience persistent feelings of sadness, hopelessness, decreased motivation, energy and anhedonia. These may in turn affect their functioning, and they are therefore more inclined to report poorer QOL [39].
Among those with psychosis, Malays were positively associated with VT, SF and MCS, while Indians were positively associated with SF and MCS as compared to Chinese. One possible explanation may be their cultural value system, as these are unique to population groups [41,42]. Similar to individuals with MDD, those with an education lower than university were negatively associated with QOL (RP and VT)., while those who were economically inactive were negatively associated with SF. We are not able to explain this association.
In terms of nicotine dependence among the MDD sample, moderate levels of nicotine dependence were negatively associated with VT. However, this association was not observed in the psychosis sample, while no significant association was observed for the high nicotine dependence group. This could be due to the analysis being underpowered, as only four participants in the MDD group demonstrated high nicotine dependence. It has been reported that smokers experience feelings of fatigue [43]. It may be possible that the low moods might have exacerbated the feelings of fatigue in the MDD sample or the fatigue may be due to smoking-related disease. Despite most smokers wanting to quit [29], many perceive that smoking provides them with mental health benefits. Smokers describe smoking as being able to alleviate emotional problems such as feelings of depression and anxiety, reduce the effect of stigma, stabilise mood, and for relaxation as well as relieving stress [44,45]. However, there is evidence indicating otherwise. A meta-analysis reported that smokers have poorer mental health as compared to those who have quit [21]. The authors found that quitting was associated with a decrease in anxiety and depression symptoms and improvement in their psychological quality of life [21]. They concluded that should individuals with mental disorders cease smoking, it is unlikely to exacerbate their symptoms and might be therapeutic instead [21].
Among the psychosis subgroup, individuals with high levels of nicotine dependence had poorer mental QOL in domain RE, MH and MCS. Individuals with psychosis typically experience discrimination in society [46]. They are more likely to live in a state of hardship partly due to the disorder itself, as it can lead to loss of employment, housing, and conflict with family members [46]. This stigma of being shunned by society can lead to social marginalization, discrimination in access to and quality of health services, and impoverishment, thus affecting QOL. To mitigate these, individuals may smoke heavily to manage mood, have a sense of control, self-medicate, and be socially accepted [44]. A study looking at community living psychiatric clients described their most comforting times being when their nurses spent time smoking with them. They felt that during this time they were less judgmental and were connected to them as a whole person and not a fragmented being [44]. Another study looking at homelessness reported a sense of camaraderie among smokers who used smoking as a way to initiate social interaction with others [47].
There were some limitations in this study. Firstly, our study was cross-sectional in nature; there was no way of determining causality in the association between smoking and QOL. Secondly, we did not collect information on physical illnesses that may affect their QOL. Thirdly, we did not assess the participant’s illness severity, which may be related to the degree of nicotine dependence. Lastly, we used face-to-face interviews, and participants may not have reported accurate cigarette consumption due to social desirability. This is especially true for females, where there is a social expectation that they should not smoke, as it is inappropriate or unfeminine [48]. On the other hand, males may over-report their cigarette consumption to portray a more “cool” or “tough” image.
Given the limitations, future research could expand the scope of the current study by looking at how cutting down on cigarettes and smoking cessation over multiple timepoints affects QOL. Nevertheless, the study adds insight into the smoking behaviour and QOL among the psychiatric population in Singapore and provides preliminary information that will aid in the planning of smoking cessation programs.

7. Conclusions

The prevalence of nicotine dependence among the psychiatric population was seven times higher than the general population. Although this figure is much higher than the general population, it is in line with the international prevalence among the psychiatric population. Individuals with psychotic disorder generally reported better QOL scores across all subdomains as compared to those with MDD. Furthermore varying levels of nicotine dependence affected those diagnosed with MDD and psychosis differently. The reasons behind the higher prevalence of smoking and higher nicotine dependence among the psychiatric population is multi-faceted, ranging from the need self-medication to gaining social acceptance. Despite the perceieved benefits of managing symptoms of anxiety and bonding with other smokers in their community, studies suggested that in the long-term, smoking results in poorer mental and physical health, especially among the psychiatric patients [21].
The high rates of smoking and nicotine dependence among the psychiatric population are worrying, as smoking greatly increases the risk of other health issues. Public health professionals can be more aggressive in intervening to reduce nicotine consumption as the first step. Health care providers, especially in mental health institutions, may wish to periodically assess their clients’ smoking patterns and behaviours. Gradual reduction of smoking or harm reduction may be introduced to those who are undecided on quitting, while programs that assist with quitting may be introduced to those who are motivated. Costs associated with smoking cessation, such as nicotine replacement therapy, could be subsidized to ensure affordability. Finally, some psychoeducation on the long-term effects of smoking could be introduced to this population to help them understand the insidious effects of long-term heavy smoking. Helping them identify healthier ways of coping with their symptoms and gaining social acceptance could go a long way to improve the physical, mental and social wellbeing of this population.

Author Contributions

Conceptualization, P.V.A. and M.S.; data curation, V.S.; formal analysis, E.A.; funding acquisition, P.V.A. and M.S.; investigation, P.W., P.V.A., V.S., F.D., K.R., Y.Y.L., L.C., W.L.T., S.V., Y.M.M. and M.S.; methodology, V.A., V.S., F.D., K.R., Y.M.M., S.V. and M.S.; project administration, P.V.A. and M.S.; resources, P.V.A., S.V., Y.M.M. and M.S.; software, P.V.A., E.A. and M.S.; supervision, P.V.A. and M.S.; validation, P.V.A., E.A. and V.S.; visualization, P.V.A. and M.S.; writing—original draft, P.W.; writing—review and editing, E.A., P.V.A., V.S., F.D., K.R., Y.Y.L., L.C., W.L.T., S.V., Y.M.M. and M.S. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Medical Research Council Centre Grant Seed Funding (NMRC/CG/M002/2017_IMH).

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Research Review Board and Domain Specific Review Board (DSRB) of Institute of Mental Health and National Healthcare Group (protocol Ref: 2018/00772; date of approval; 16 August 2018).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to institutional policies.

Acknowledgments

We acknowledge the contributions of clinicians and other allied health staff in the referral of the patients to the study.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analysis, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. WHO Launches New Report on Global Tobacco Use Trends. Available online: https://www.who.int/news/item/19-12-2019-who-launches-new-report-on-global-tobacco-use-trends (accessed on 2 December 2020).
  2. Health Risks of Smoking Tobacco. Available online: https://www.cancer.org/healthy/stay-away-from-tobacco/health-risks-of-tobacco/health-risks-of-smoking-tobacco.html (accessed on 10 July 2021).
  3. Banks, E.; Joshy, G.; Weber, M.F.; Liu, B.; Grenfell, R.; Egger, S.; Paige, E.; Lopez, A.D.; Sitas, F.; Beral, V. Tobacco smoking and all-cause mortality in a large Australian cohort study: Findings from a mature epidemic with current low smoking prevalence. BMC Med. 2015, 13, 1–10. Available online: https://pubmed.ncbi.nlm.nih.gov/25857449/ (accessed on 2 December 2020). [CrossRef] [Green Version]
  4. Bhatnagar, A.; Whitsel, L.P.; Blaha, M.J.; Huffman, M.D.; Krishan-Sarin, S.; Maa, J.; Rigotti, N.; Robertson, R.M.; Warner, J.J.; On behalf of the American Heart Association. New and Emerging Tobacco Products and the Nicotine Endgame: The Role of Robust Regulation and Comprehensive Tobacco Control and Prevention: A Presidential Advisory From the American Heart Association. Circulation 2019, 139, e937–e958. [Google Scholar] [CrossRef]
  5. Hoffman, S.J.; Poirier, M.J.P.; Katwyk, S.R.V.; Baral, P.; Sritharan, L. Impact of the WHO Framework Convention on Tobacco Control on global cigarette consumption: Quasi-experimental evaluations using interrupted time series analysis and in-sample forecast event modelling. BMJ 2019, 365. Available online: https://www.bmj.com/content/365/bmj.l2287 (accessed on 7 December 2020). [CrossRef] [Green Version]
  6. MOH. National Health Survey 2010. Available online: https://www.moh.gov.sg/resources-statistics/reports/national-health-survey-2010 (accessed on 5 December 2020).
  7. MOH. National Population Health Survey 2016/17. Available online: https://www.moh.gov.sg/resources-statistics/reports/national-population-health-survey-2016-17 (accessed on 5 December 2020).
  8. Wang, P.; Abdin, E.; Sambasivam, R.; Chong, S.A.; Vaingankar, J.A.; Subramaniam, M. Smoking and Socio-demographic correlates of BMI. BMC Public Health 2016, 16, 500. [Google Scholar] [CrossRef] [Green Version]
  9. Shahwan, S.; Abdin, E.; Shafie, S.; Chang, S.; Sambasivam, R.; Zhang, Y.; Vaingankar, J.A.; Teo, Y.Y.; Heng, D.; Chong, S.A.; et al. Prevalence and correlates of smoking and nicotine dependence: Results of a nationwide cross-sectional survey among Singapore residents. BMJ Open 2019, 9, e032198. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803088/ (accessed on 5 December 2020). [CrossRef] [Green Version]
  10. Lasser, K.; Boyd, J.W.; Woolhandler, S.; Himmelstein, D.U.; McCormick, D.; Bor, D.H. Smoking and mental illness: A population-based prevalence study. JAMA 2000, 284, 2606–2610. [Google Scholar] [CrossRef]
  11. RCP London. Smoking and Mental Health. 2013. Available online: https://www.rcplondon.ac.uk/projects/outputs/smoking-and-mental-health (accessed on 7 December 2020).
  12. Ziedonis, D.; Williams, J.M.; Smelson, D. Serious Mental Illness and Tobacco Addiction: A Model Program to Address This Common but Neglected Issue. Am. J. Med. Sci. 2003, 326, 223–230. [Google Scholar] [CrossRef]
  13. Winterer, G. Why do patients with schizophrenia smoke? Curr. Opin. Psychiatry 2010, 23, 112–119. [Google Scholar] [CrossRef]
  14. WHO. Excess Mortality in Persons with Severe Mental Disorders. Available online: https://www.who.int/mental_health/evidence/excess_mortality_meeting_report.pdf?ua=1 (accessed on 10 December 2021).
  15. Bobes, J.; Garcia-Portilla, M.P.; Bascaran, M.T.; Saiz, P.A.; Bouzoño, M. Quality of life in schizophrenic patients. Dialogues Clin. Neurosci. 2007, 9, 215–226. [Google Scholar]
  16. Correll, C.U.; Schooler, N.R. Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment. Neuropsychiatr. Dis. Treat. 2020, 16, 519–534. [Google Scholar] [CrossRef] [Green Version]
  17. Zlotnick, C.; Kohn, R.; Keitner, G.; Della Grotta, S.A. The relationship between quality of interpersonal relationships and major depressive disorder: Findings from the National Comorbidity Survey. J. Affect. Disord. 2000, 59, 205–215. [Google Scholar] [CrossRef]
  18. The World Health Organization. WHOQOL: Measuring Quality of Life. Available online: https://www.who.int/toolkits/whoqol (accessed on 8 December 2020).
  19. Bjordal, K. Impact of quality of life measurement in daily clinical practice. Ann. Oncol. 2004, 15, iv279–iv282. [Google Scholar] [CrossRef]
  20. Haraldstad, K.; Wahl, A.; Andenæs, R.; Andersen, J.R.; Andersen, M.H.; Beisland, E.; Borge, C.R.; Engebretsen, E.; Eisemann, M.; Halvorsrud, L.; et al. A systematic review of quality of life research in medicine and health sciences. Qual. Life Res. 2019, 28, 2641–2650. [Google Scholar] [CrossRef] [Green Version]
  21. Taylor, G.; McNeill, A.; Girling, A.; Farley, A.; Lindson-Hawley, N.; Aveyard, P. Change in mental health after smoking cessation: Systematic review and meta-analysis. BMJ 2014, 348. [Google Scholar] [CrossRef] [Green Version]
  22. Anda, R.F.; Williamson, D.F.; Escobedo, L.G.; Mast, E.E.; Giovino, G.A.; Remington, P.L. Depression and the Dynamics of Smoking: A National Perspective. JAMA 1990, 264, 1541–1545. [Google Scholar] [CrossRef]
  23. Goldenberg, M.; Danovitch, I.; IsHak, W.W. Quality of life and smoking. Am. J. Addict. 2014, 23, 540–562. [Google Scholar] [CrossRef]
  24. Psychiatry Online. DSM Library. Available online: https://dsm.psychiatryonline.org/doi/pdf/10.1176/appi.books.9780890420249.dsm-iv-tr (accessed on 28 September 2020).
  25. Asma, S.; World Health Organization; CDC Foundation; World Lung Foundation; Centers for Disease Control and Prevention (U.S.). The GATS Atlas: Global Adult Tobacco Survey. 2015. Available online: https://stacks.cdc.gov/view/cdc/51993 (accessed on 10 December 2020).
  26. NHIS. Adult Tobacco Use—Glossary. 2019. Available online: https://www.cdc.gov/nchs/nhis/tobacco/tobacco_glossary.htm (accessed on 28 September 2020).
  27. Asharani, P.V.; Ling Seet, V.A.; Abdin, E.; Siva Kumar, F.D.; Wang, P.; Roystonn, K.; Lee, Y.Y.; Cetty, L.; Teh, W.L.; Verman, S.; et al. Smoking and Mental Illness: Prevalence, Patterns and Correlates of Smoking and Smoking Cessation among Psychiatric Patients. Int. J. Environ. Res. Public Health 2020, 17, 5571. [Google Scholar] [CrossRef]
  28. Heatherton, T.F.; Kozlowski, L.T.; Frecker, R.C.; Fagerstrom, K.-O. The Fagerström Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. Br. J. Addict. 1991, 86, 1119–1127. [Google Scholar] [CrossRef]
  29. Weinberger, A.H.; Reutenauer, E.L.; Allen, T.M.; Termine, A.; Vessicchio, J.C.; Sacco, K.A.; Easton, C.J.; McKee, S.A.; George, T.P. Reliability of the Fagerström Test for Nicotine Dependence, Minnesota Nicotine Withdrawal Scale, and Tiffany Questionnaire for Smoking Urges in Smokers with and without Schizophrenia. Drug Alcohol Depend. 2007, 86, 278–282. [Google Scholar] [CrossRef]
  30. Ware, J.E.; Kosinski, M.; Keller, S.D. A 12-Item Short-Form Health Survey: Construction of Scales and Preliminary Tests of Reliability and Validity. Med. Care 1996, 34, 220–233. [Google Scholar] [CrossRef] [Green Version]
  31. Lam, C.L.K.; Tse, E.Y.Y.; Gandek, B. Is the standard SF-12 health survey valid and equivalent for a Chinese population? Qual. Life Res. Int. J. Qual. Life Asp. Treat. Care Rehabil. 2005, 14, 539–547. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Tan, M.L.; Wee, H.L.; Salim, A.; Lee, J.; Ma, S.; Heng, D.; Shyong Tai, E.; Thumboo, J. Validity of a Revised Short Form-12 Health Survey Version 2 in Different Ethnic Populations. Ann. Acad. Med. Singap. 2016, 45, 9. [Google Scholar]
  33. Smith, P.H.; Mazure, C.M.; McKee, S.A. Smoking and mental illness in the U.S. population. Tob. Control 2014, 23, e147–e153. [Google Scholar] [CrossRef]
  34. Grant, B.F.; Hasin, D.S.; Chou, S.P.; Stinson, F.S.; Dawson, D.A. Nicotine dependence and psychiatric disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 2004, 61, 1107–1115. [Google Scholar] [CrossRef]
  35. Mroczek, D.K.; Spiro, A. Change in life satisfaction during adulthood: Findings from the veterans affairs normative aging study. J. Pers. Soc. Psychol. 2005, 88, 189–202. [Google Scholar] [CrossRef] [Green Version]
  36. Easterlin, R.A. Life cycle happiness and its sources: Intersections of psychology, economics, and demography. J. Econ. Psychol. 2006, 27, 463–482. [Google Scholar] [CrossRef] [Green Version]
  37. Chan, A.; Malhotra, C.; Do, Y.K.; Malhotra, R.; Ostbye, T. Self reported pain severity among multiethnic older Singaporeans: Does adjusting for reporting heterogeneity matter? Eur. J. Pain Lond. Engl. 2011, 15, 1094–1099. [Google Scholar] [CrossRef]
  38. Easterbrook, M.J.; Kuppens, T.; Manstead, A.S.R. The Education Effect: Higher Educational Qualifications are Robustly Associated with Beneficial Personal and Socio-political Outcomes. Soc. Indic. Res. 2016, 126, 1261–1298. [Google Scholar] [CrossRef] [Green Version]
  39. Tan, X.W.; Seow, E.; Abdin, E.; Verma, S.; Sim, K.; Chong, S.A.; Subramaniam, M. Subjective quality of life among patients with schizophrenia spectrum disorder and patients with major depressive disorder. BMC Psychiatry 2019, 19, 267. [Google Scholar] [CrossRef] [Green Version]
  40. Goppoldova, E.; Dragomirecka, E.; Motlova, L.; Hajek, T. Subjective Quality of Life in Psychiatric Patients: Diagnosis and Illness-Specific Profiles. Can. J. Psychiatry 2008, 53, 587–593. [Google Scholar] [CrossRef] [Green Version]
  41. Ng, T.P.; Lim, L.C.C.; Jin, A.; Shinfuku, N. Ethnic differences in quality of life in adolescents among Chinese, Malay and Indians in Singapore. Qual. Life Res. 2005, 14, 1755–1768. [Google Scholar] [CrossRef] [PubMed]
  42. Thumboo, J.; Fong, K.Y.; Machin, D.; Chan, S.P.; Soh, C.H.; Leong, K.H.; Feng, P.-H.; Thio, S.-T.; Boey, M.-L. Quality of life in an urban Asian population: The impact of ethnicity and socio-economic status. Soc. Sci. Med. 2003, 56, 1761–1772. [Google Scholar] [CrossRef]
  43. Furlanetto, K.C.; Mantoani, L.C.; Bisca, G.; Morita, A.A.; Zabatiero, J.; Proença, M.; Kovelis, D.; Pitta, F. Reduction of physical activity in daily life and its determinants in smokers without airflow obstruction. Respirology 2014, 19, 369–375. [Google Scholar] [CrossRef]
  44. Lawn, S.J.; Pols, R.G.; Barber, J.G. Smoking and quitting: A qualitative study with community-living psychiatric clients. Soc. Sci. Med. 2002, 54, 93–104. [Google Scholar] [CrossRef]
  45. Clancy, N.; Zwar, N.; Richmond, R. Depression, smoking and smoking cessation: A qualitative study. Fam. Pract. 2013, 30, 587–592. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Hampson, M.E.; Watt, B.D.; Hicks, R.E. Impacts of stigma and discrimination in the workplace on people living with psychosis. BMC Psychiatry 2020, 20, 288. [Google Scholar] [CrossRef]
  47. Okuyemi, K.S.; Caldwell, A.R.; Thomas, J.L.; Born, W.; Richter, K.P.; Nollen, N.; Braunstein, K.; Ahluwalia, J.S. Homelessness and smoking cessation: Insights from focus groups. Nicotine Tob. Res. Off. J. Soc. Res. Nicotine Tob. 2006, 8, 287–296. [Google Scholar] [CrossRef] [PubMed]
  48. Pampel, F.C. Global Patterns and Determinants of Sex Differences in Smoking. Int. J. Comp. Sociol. 2006, 47, 466–487. [Google Scholar] [CrossRef] [Green Version]
Table 1. Socio-demographic characteristics of psychiatric patients.
Table 1. Socio-demographic characteristics of psychiatric patients.
MDD (n = 175)Psychotic Disorder (n = 203)
n%n%
Overall
Age
21–4016666.37135.0
41–655933.713265.0
Gender
Male9051.412059.1
Female8533.78340.9
Ethnicity
Chinese11766.916078.8
Malay2816.02713.3
Indian2614.9136.4
Others42331.5
Educational level
Primary school179.73416.7
Secondary school2816.07436.5
Pre-university (JC/diploma)6738.34321.2
Vocational Institute/ITE2614.92713.3
University3721.12512.3
Marital status
Married3318.92914.3
Single11565.714772.4
Separated/divorced/widowed2715.42713.3
Employment status
Employed8448.09446.3
Unemployed7140.69546.8
Economically inactive2011.4146.9
Monthly Income
Below SGD $200012973.717787.2
SDG $2000 to SGD $39993520.0199.4
SGD $4000 and above116.373.4
Smoking Status
Non-Smoker8246.911456.2
Ever-smoker9353.18943.8
FTND
Non-smoker8246.911456.2
Low (0–4)6436.63014.8
Moderate (5–7)2514.33919.2
High (8 and above)42.3209.9
MDD only includes unipolar depression, those with bipolar disorders were excluded.
Table 2. Association between socio-demographic with QOL in the MDD sample (n = 175).
Table 2. Association between socio-demographic with QOL in the MDD sample (n = 175).
PhysicalMentalSummary
PF (β)RP (β)BP (β)GH (β)VT (β)SF (β)RE (β)MH (β)PCS (β)MCS (β)
Age (Ref: 21–40)
41–65−3.74−1.78−3.510.140.863.254.453.92−5.016.33
Gender (Ref: Male)
Female−1.27−2.350.510.44−2.84−0.54−1.930.04−0.92−1.05
Ethnicity (Ref: Chinese)
Malay1.03−0.200.59−1.72−1.00−2.61−2.59−3.791.45−4.16
Indian−1.55−3.24−6.48−3.870.99−4.490.141.13−5.031.07
Others−1.86−2.881.816.213.82462.28−1.91−1.322.65−0.32
Marital status (Ref: Married)
Single−3.06−1.72−6.24−0.74−4.550.20.120.12−4.250.63
Separated/divorced/widowed−2.64−0.14−4.30−0.99−2.79−0.800.551.48−3.281.14
Educational level (Ref: University)
Primary school−1.58−1.25−4.56−3.15−0.652.51.42−1.59−3.301.37
Secondary school−1.49−2.90−7.04−3.19−5.14−0.81−1.54−6.55−3.09−3.84
Pre-university (JC/diploma)1.320.870.11−3.06−5.26−1.29−3.91−4.221.68−5.70
Vocational Institute/ITE−0.70−3.05−5.141.96−0.07−1.24−1.49−1.03−1.99−0.49
Employment status (Ref: Employed)
Unemployed−0.75−2.94−1.141.08−2.43−1.21−3.85−2.19−0.28−3.02
Economically inactive−1.060.99 3.18−1.64−4.27−0.80.451.230.02−0.61
Monthly Income (Ref: Below SGD $2000)
SDG $2000 to SGD $39992.18−0.211.9−1.22−4.421.160.13−1.091.23−1.86
SGD $4000 and above−0.12−1.96−4.4−2.2−2.230.17−0.091.63−3.10.99
MDD only included unipolar depression, those with bipolar disorder were excluded. Linear Regression (controlled for socio-demographic factors and nicotine dependence). PF: Physical functioning; RP: Role limitations due to physical problems; BP: Bodily pain; GH: General health; VT: Vitality; SF: Social functioning; RE: Role limitations due to emotional problems; MH: Mental health; PCS: Physical Component Score; MCS: Mental Component Score.
Table 3. Association between socio-demographic with QOL in the psychotic sample (n = 203).
Table 3. Association between socio-demographic with QOL in the psychotic sample (n = 203).
PhysicalMentalSummary
PF (β)RP (β)BP (β)GH (β)VT (β)SF (β)RE (β)MH (β)PCS (β)MCS (β)
Age (Ref: 21–40)
41–65−2.37−2.18−3.14−0.90−0.43−0.561.811.1−3.592.2
Gender (Ref: Male)
Female−0.241.19−1.22−0.530.343.012.040.21−0.661.91
Ethnicity (Ref: Chinese)
Malay−1.160.36−3.810.346.14.90.633.3−2.205.21
Indian−2.153.54−2.513.365.948.894.973.260.47.29
Others−1.60−1.45−3.623.40.22−4.771.061.45−1.970.78
Marital status (Ref: Married)
Single−0.620.573.040.850.742.53−1.47−1.761.79−0.88
Separated/divorced/widowed−3.18−0.720.683.02−0.270.44−1.701.32−0.610.67
Educational level (Ref: University)
Primary school−0.99−0.97−4.89−5.39−2.920.861.62−3.36−3.32−0.48
Secondary school−3.19−1.61−0.76−3.13−0.51−0.82−1.49−2.66−2.07−1.22
Pre-university (JC/diploma)−2.70−2.74−0.83−1.33−0.621.44−1.23−1.38−2.190.1
Vocational Institute/ITE−2.80−5.81−2.88−1.21−8.41−3.62−5.57−3.37−2.84−5.35
Employment status (Ref: Employed)
Unemployed−1.04−1.61−2.95−1.13−2.00−1.53−2.61−1.46−1.45−1.98
Economically inactive0.070.47−2.940.98−4.31−6.97−2.582.030.38−4.80
Monthly Income (Ref: Below SGD $2000)
SDG $2000 to SGD $39992.080.361.293.34−0.101.340.98−0.221.87−0.68
SGD $4000 and above2.173.851.534.691.713.646.912.991.974.64
MDD only included unipolar depression, bipolar disorders were excluded. Linear Regression (controlled for socio-demographics factors and nicotine dependence). PF: Physical functioning; RP: Role limitations due to physical problems; BP: Bodily pain; GH: General health; VT: Vitality; SF: Social functioning; RE: Role limitations due to emotional problems; MH: Mental health; PCS: Physical Component Score; MCS: Mental Component Score.
Table 4. Association of Nicotine Dependence with QOL among those with MDD (n = 175) and Psychotic Disorder (n = 203).
Table 4. Association of Nicotine Dependence with QOL among those with MDD (n = 175) and Psychotic Disorder (n = 203).
PhysicalMentalSummary
PFRPBPGHVTSFREMHPCSMCS
MDD
FTND (Ref. Non-smoker)
Low (0–4)0.151.382.090.920.35−0.00−1.43−2.392.26−2.11
Moderate (5–7)−1.28−0.390.810.44−5.11−1.16−4.70−5.121.58−5.77
High (8 and above)0.3−9.276.25.43−6.54−6.43−9.900.11.94−7.12
Physical Mental Summary
PFRPBPGHVTSFREMHPCSMCS
Psychotic Disorder
FTND (Ref. Non-smoker)
Low (0–4)4.13.82−0.211.63−0.49−1.151.970.842.85−0.58
Moderate (5–7)3.024.022.80.592.14.732.29−0.463.421.06
High (8 and above)−0.29−3.660.050.9−2.15−1.80−7.81−6.591.74−7.09
MDD only includes unipolar depression, those with bipolar disorders were excluded. Linear Regression (controlled for socio-demographics factors). PF: Physical functioning; RP: Role limitations due to physical problems; BP: Bodily pain; GH: General health; VT: Vitality; SF: Social functioning; RE: Role limitations due to emotional problems; MH: Mental health; PCS: Physical Component Score; MCS: Mental Component Score.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Wang, P.; Abdin, E.; Asharani, P.V.; Seet, V.; Devi, F.; Roystonn, K.; Lee, Y.Y.; Cetty, L.; Teh, W.L.; Verma, S.; et al. Nicotine Dependence in Patients with Major Depressive Disorder and Psychotic Disorders and Its Relationship with Quality of Life. Int. J. Environ. Res. Public Health 2021, 18, 13035. https://doi.org/10.3390/ijerph182413035

AMA Style

Wang P, Abdin E, Asharani PV, Seet V, Devi F, Roystonn K, Lee YY, Cetty L, Teh WL, Verma S, et al. Nicotine Dependence in Patients with Major Depressive Disorder and Psychotic Disorders and Its Relationship with Quality of Life. International Journal of Environmental Research and Public Health. 2021; 18(24):13035. https://doi.org/10.3390/ijerph182413035

Chicago/Turabian Style

Wang, Peizhi, Edimansyah Abdin, P.V. Asharani, Vanessa Seet, Fiona Devi, Kumarasan Roystonn, Ying Ying Lee, Laxman Cetty, Wen Lin Teh, Swapna Verma, and et al. 2021. "Nicotine Dependence in Patients with Major Depressive Disorder and Psychotic Disorders and Its Relationship with Quality of Life" International Journal of Environmental Research and Public Health 18, no. 24: 13035. https://doi.org/10.3390/ijerph182413035

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop